TANDEM DIABETES CARE INC (TNDM) › Shareholders' EquityTANDEM DIABETES CARE INC (TNDM) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: -$71.30M2012: -$106.05M2013: $115.54M2014: $54.57M2015: $63.47M2016: -$5.93M2017: -$29.15M2018: $131.28M2019: $194.98M2020: $366.31M2021: $433.11M2022: $439.95M2023: $313.63M2024: $263.10M2025: $155.17M$155.17M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$155.17M-41.0%2024$263.10M-16.1%2023$313.63M-28.7%2022$439.95M+1.6%2021$433.11M+18.2%2020$366.31M+87.9%2019$194.98M+48.5%2018$131.28M+550.4%2017-$29.15M-391.8%2016-$5.93M-109.3%2015$63.47M+16.3%2014$54.57M-52.8%2013$115.54M+208.9%2012-$106.05M-48.8%2011-$71.30M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share